| Using supercritical fluid technology as a green alternative during the preparation of drug delivery systems P Chakravarty, A Famili, K Nagapudi, MA Al-Sayah Pharmaceutics 11 (12), 629, 2019 | 103 | 2019 |
| Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2 M Zak, CA Hurley, SI Ward, P Bergeron, K Barrett, M Balazs, WS Blair, ... Journal of medicinal chemistry 56 (11), 4764-4785, 2013 | 77 | 2013 |
| Characterization of pharmaceutical cocrystals and salts by dynamic nuclear polarization-enhanced solid-state NMR spectroscopy L Zhao, MP Hanrahan, P Chakravarty, AG DiPasquale, LE Sirois, ... Crystal Growth & Design 18 (4), 2588-2601, 2018 | 69 | 2018 |
| Chemically diverse group I p21-activated kinase (PAK) inhibitors impart acute cardiovascular toxicity with a narrow therapeutic window J Rudolph, LJ Murray, CO Ndubaku, T O’Brien, E Blackwood, W Wang, ... Journal of medicinal chemistry 59 (11), 5520-5541, 2016 | 64 | 2016 |
| A Rational Approach towards Development of Amorphous Solid Dispersions: Experimental and Computational techniques P Chakravarty, JW Lubach, J Hau, K Nagapudi International Journal of Pharmaceutics, 2017 | 38 | 2017 |
| Insights into the dehydration behavior of thiamine hydrochloride (vitamin B1) hydrates: Part II P Chakravarty, RT Berendt, EJ Munson, VG Young Jr, R Govindarajan, ... Journal of pharmaceutical sciences 99 (4), 1882-1895, 2010 | 38 | 2010 |
| Insights into the dehydration behavior of thiamine hydrochloride (vitamin B1) hydrates: part I SRG Chakravarty Paroma, Berendt Robert T, Munson Eric Journal of Pharmaceutical Sciences 99 (2), 816-827, 2009 | 38* | 2009 |
| Characterization and structure analysis of thiamine hydrochloride methanol solvate P Chakravarty, R Suryanarayanan Crystal growth & design 10 (10), 4414-4420, 2010 | 26 | 2010 |
| Phase transformation in thiamine hydrochloride tablets: influence on tablet microstructure, physical properties, and performance P Chakravarty, R Suryanarayanan, R Govindarajan Journal of pharmaceutical sciences 101 (4), 1410-1422, 2012 | 20 | 2012 |
| Monitoring phase transformations in intact tablets of trehalose by FT-Raman spectroscopy P Chakravarty, SP Bhardwaj, L King, R Suryanarayanan AAPS PharmSciTech 10, 1420-1426, 2009 | 20 | 2009 |
| Crystal forms of tolbutamide from acetonitrile and 1-octanol: effect of solvent, humidity and compression pressure P Chakravarty, KS Alexander, AT Riga, K Chatterjee International journal of pharmaceutics 288 (2), 335-348, 2005 | 20 | 2005 |
| Investigation of solution and vapor phase mediated phase transformation in thiamine hydrochloride P Chakravarty, R Govindarajan, R Suryanarayanan Journal of pharmaceutical sciences 99 (9), 3941-3952, 2010 | 19 | 2010 |
| In Situ Characterization of Waters of Hydration in a Variable-Hydrate Active Pharmaceutical Ingredient Using 35Cl Solid-State NMR and X-ray Diffraction DA Hirsh, ST Holmes, P Chakravarty, AA Peach, AG DiPasquale, ... Crystal Growth & Design 19 (12), 7349-7362, 2019 | 18 | 2019 |
| Cyclodextrin reduces intravenous toxicity of a model compound P Mantik, M Xie, H Wong, H La, RW Steigerwalt, U Devanaboyina, ... Journal of pharmaceutical sciences 108 (6), 1934-1943, 2019 | 12 | 2019 |
| The importance of water-solid interactions in small molecule drug development: An industry perspective P Chakravarty, K Nagapudi TrAC Trends in Analytical Chemistry 140, 116276, 2021 | 10 | 2021 |
| Identification of a potential conformationally disordered mesophase in a small molecule: experimental and computational approaches P Chakravarty, S Bates, L Thomas Molecular Pharmaceutics 10 (8), 2809-2822, 2013 | 9 | 2013 |
| Process Development Overcomes a Challenging Pd-Catalyzed C–N Coupling for the Synthesis of RORc Inhibitor GDC-0022 LE Sirois, D Lao, J Xu, R Angelaud, J Tso, B Scott, P Chakravarty, ... Organic Process Research & Development 24 (4), 567-578, 2020 | 8 | 2020 |
| Determination of fragility in organic small molecular glass forming liquids: comparison of calorimetric and spectroscopic data and commentary on pharmaceutical importance P Chakravarty, K Pandya, K Nagapudi Molecular Pharmaceutics 15 (3), 1248-1257, 2018 | 8 | 2018 |
| Characterization of a water–solid interaction in a partially ordered system P Chakravarty, JW Lubach Molecular Pharmaceutics 10 (11), 4294-4300, 2013 | 8 | 2013 |
| Isothermal Crystallization Monitoring and Time–Temperature-Transformation of Amorphous GDC-0276: Differential Scanning Calorimetric and Rheological Measurements S Cheng, P Chakravarty, K Nagapudi, GB McKenna Molecular Pharmaceutics 18 (1), 158-173, 2020 | 5 | 2020 |
Karthik NagapudiDistinguished Scientist, GenentechAdresse e-mail validée de gene.com
